Skip to content

Sciatic Nerve Block for Ankle and Leg Fracture Manipulation in the Emergency Department

Ultrasound-guided Sciatic Nerve Block for Distal Leg and Ankle Fracture Manipulation in the Emergency Department: A Feasibility Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06329752
Acronym
AnkleMan
Enrollment
30
Registered
2024-03-26
Start date
2024-05-31
Completion date
2025-06-30
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Fractures, Leg Fracture

Brief summary

The goal of this feasibility clinical trial is to assess the acceptability of ultrasound-guided sciatic nerve block when performed at Emergency Departments for manipulation and temporary stabilization of distal leg and ankle fractures. The trial aims to assess: * The acceptability of sciatic nerve block * The technical feasibility of sciatic nerve block * The technical success of sciatic nerve block * The analgesic efficacy of sciatic nerve block In addition to that, this study aims to * Describe patient-reported and physician-reported satisfaction * Assess the Adverse Event rate at 48 hours post intervention

Interventions

PROCEDUREUltrasound-guided Sciatic Nerve block (20 mL of 2% Lidocaine)

Patients will be scanned with the ultrasound machine to determine the technical feasibility of sciatic nerve blocks. If feasible, one of the following techniques will be performed a) popliteal sciatic nerve block, with either lateral or posterior approach; b) CAPS (crosswise approach to popliteal sciatic) block, with either lateral to medial or anterolateral to posteromedial approach; c) subgluteal sciatic nerve block; d) transgluteal sciatic nerve block. In all cases, 20 mL of 2% Lidocaine will be used.

Sponsors

Fondazione IRCCS Policlinico San Matteo di Pavia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Interventional, single-arm, feasibility trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 * Confirmed radiological diagnosis of distal tibia fracture (Group 43 according to AO classification, all subtypes included); or malleolar fracture (Group 44 according to AO classification, all subtypes included); or distal fibula fracture (Group 4F3 according to AO classification, both the two subtypes included); or any combination of the fracture patterns described * Fractures requiring manipulation in the ED to achieve temporary stabilization either as manual reduction and cast immobilization; or calcaneal pin traction (as per local policy or treating physician's preference) * Capacity to understand the aim of the study, the potential benefits and harms of the proposed intervention * Capacity to provide consent * Capacity to provide a self-assessment of pain using the written VAS Scale

Exclusion criteria

* Fractures that do not require any form of manipulation in the ED according to the treating physician (e.g., fractures with minimal or no displacement of the bony fragments, that are immobilized in a posterior leg cast by the nursing stuff/physicians assistants without any painful manipulations of the bony fragments performed by the physician) * Open fractures * Perisynthetic or periprosthetic fractures * Distal leg/ankle fractures with neurovascular compromise * Clinical signs of compartment syndrome * Skin infection at the needle entry sites * Diabetic neuropathy or any other known form of neuropathy that causes reduced sensation in the sciatic and/or femoral nerve territory * Charcot-Marie-Tooth disease * Known allergy to local anaesthetics or opioids * Hemodynamic instability * Known diagnosis of severe cognitive impairment * Dementia and/or delirium (defined by a 4AT score ≥ 2) * Lack of capacity to provide consent and to understand the aim of the study * Patient's refusal to participate in the study * BMI\>35 * Body weight \< 40 Kg

Design outcomes

Primary

MeasureTime frameDescription
To assess the technical feasibility of ultrasound-guided sciatic nerve block when performed at Emergency Departments for manipulation and temporary stabilization of distal leg and ankle fractures.From patient recruitment until sciatic nerve scanning (an estimated time frame of 30 minutes)Percentage of patients for whom the block is deemed technically feasible by the investigator in charge of this task

Secondary

MeasureTime frameDescription
Technical success of US-guided sciatic nerve block15 Minutes post US-guided sciatic nerve blockPercentage of patients treated with sciatic nerve block who develop complete or mild- score 0 or 1 - sensory deficit 15 minutes post block
Analgesic efficacy of US-guided sciatic nerve blockAn estimated average time of 15 minutes after the beginning of fracture manipulationPercentage of patients manipulated after a successful sciatic nerve block who report Pain Max \< 40 mm
Patient-reported and physician-reported satisfactionAn estimated average time of 30 minutes after the beginning of fracture manipulationPatient's satisfaction and Treating physician's satisfaction assessed with a 5-points Likert scale.

Other

MeasureTime frameDescription
Safety EndpointIn the first 48 hours post interventionNumber and type of adverse events in the first 48 hours post intervention

Countries

Italy

Contacts

Primary ContactSanti Di Pietro, MD
santi.dipietro@unipv.it+39 0382 502750

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026